A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader

    A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

    circles-1

    Tag_icon

    Regulatory Affairs

    Medicine-icon

    Pharma & Biotech

    share-iconshare-icon-mob Share

    X (Twitter) icon\ \ X (Twitter) LinkedIn icon\ \ LinkedIn WhatsApp icon\ \ WhatsApp Copy link icon\ \ Copy link Mail icon\ \ Mail

    As one of the world’s leading pharmaceutical companies, our client develops and distributes innovative medicinal products that improve patient care.

    Operating across diverse markets, they must ensure that Product Information (PI) remains clear, precise, and compliant in multiple languages while meeting stringent regulatory requirements. With ever-evolving guidelines and tight submission deadlines, maintaining compliance across 25 EU/EEA languages is a major operational challenge.

    Read more

    1

    Challenge

    Challenge

    2

    Lightbulb_icon

    Approach

    3

    Results

    Results

    Challenge

    Challenge

    Regulatory & linguistic complexity

    Since 2010, QbD Group has partnered with this pharmaceutical leader to manage the intricate post-approval linguistic review process for a family of medicinal products. The complexity of coordinating multiple translations, ensuring alignment with QRD guidelines, and adhering to EMA procedures created significant challenges, including:

    • Managing PI updates across 25 EU/EEA languages while meeting strict submission deadlines.
    • Ensuring accuracy and consistency in translations across multiple regulatory frameworks.
    • Implementing an efficient workflow to standardize processes and reduce errors.

    Discover our approach

    Approach

    Approach

    Streamlining the linguistic review process

    To ensure efficiency and accuracy, QbD Group developed a structured, standardized approach to translation management, quality control, and submission coordination. Our key strategies include:

    • Early preparation of the English PI to align with QRD guidelines before MAA or post-approval submissions.
    • Clear, well-defined processes supported by specialized software tools to ensure precision and consistency.
    • A proactive workflow to meet strict regulatory deadlines without compromising quality.

    Read more about the results

    Results

    Results

    Delivering regulatory excellence

    With deep expertise in EMA procedures, QbD Group has successfully managed over 250 linguistic review procedures, ensuring:

    • High-quality submissions that meet stringent regulatory requirements.
    • Standardized processes and automation for enhanced accuracy and efficiency.
    • A long-standing partnership built on trust, expertise, and proven results.

    By combining regulatory know-how with an efficient, structured approach, QbD Group continues to support our client in maintaining compliance and ensuring clear, accurate product information across multiple markets.

    Also need support?

    contact-mail

    Get in touch

    Need expert support for your regulatory and linguistic review processes?

    Let’s discuss how QbD Group can help streamline compliance and ensure accuracy. Fill out the form and we’ll be in touch soon!

    Get in touch_QbD group-1

    First name*

    Last name*

    Professional Email*

    Company name*

    Role*

    Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther

    Department*

    Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther

    Country*

    Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

    Phone number*

    More info about your specific challenge or question*

    Industry *

    Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther

    Field of Interest at time of last SRA

    Content Type

    Content Division

    Content Title

    QbD Group is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

    • Yes, I agree to receive personalized newsletters with market insights, invitations for exclusive events and educational webinars from the QbD Group.

    • I consent to the privacy policy and understand that my personal data will be stored and processed

    *